Pharmacokinetic differences between neonatal patients and adults

Altered parameters Clinical effects

¢ + Proportion of body water |e ¢ Distribution of water-soluble drugs may

Distribution |+ Blood-brain barrier necessitate higher mg/kg dose
immaturity ¢ ¢ CNS toxicity
. e | CYP enzyme activity ¢ + Sensitivity to hepatically metabolized
Metabolism
¢ | Hepatic glucuronidation drugs

oo. e May require lower doses of renally
Elimination |* | Renal blood flow & GFR
excreted drugs

CYP = cytochrome P450; GFR = glomerular filtration rate.

